Shenzhen Yuanzheng Cell Medical Technique

Shenzhen Yuanzheng Cell Medical Technique is a clinical-stage biotechnology company based in China, specializing in the development of advanced cell-based immunotherapies for cancer. The company's core technology is the Multi-Antigen Stimulated Cell Therapy (MASCT) platform, which utilizes dendritic cells to prime T cells against multiple tumor-associated antigens, specifically targeting solid tumors. In addition to MASCT, Yuanzheng Cell is advancing a pipeline of CAR-T and TCR-T therapies for both hematological malignancies and solid cancers. The company operates a large-scale GMP manufacturing facility in Shenzhen to support its clinical trials and future commercialization efforts.